The link between a higher DOT1L expression and a worst patient’s prognosis has been confirmed also in other malignancies of the gastrointestinal tract, such as in colorectal cancer (CRC), where a positive correlation between DOT1L and MYC expression was found in several cohorts of CRC patients (Yang et al., 2019). This evidence concerns the gene DOT1L and colorectal cancer.